Under the agreement, Chiltern will provide services to EPS International from its network of offices in 23 countries throughout Europe, North America, South America and India. Similarly, EPS will provide clinical development services for the Asian region from their offices in Japan, China, Singapore, Korea and Taiwan.
Glenn Kerkhof, CEO of Chiltern, said: “Asia is becoming an increasingly attractive market for clinical trial services and finding a partner with a meaningful presence and experience of conducting clinical trials throughout Southeast Asia is an important development for Chiltern.
“With EPS as our partner in this region we continue to focus on our mission to deliver expert, high quality, clinical development services around the world.”